Showing 2981-2990 of 5909 results for "".
- Ivantis Announces 3-Year Results from FDA Clinical Trial Demonstrating Long-Term Reduction of Severe Major Surgeries for Glaucoma Patientshttps://modernod.com/news/ivantis-announces-3-year-results-from-fda-clinical-trial-demonstrating-long-term-reduction-of-severe-major-surgeries-for-glaucoma-patients/2476534/Ivantis, developer of the Hydrus Microstent, announced the 3-year results from the HORIZON pivotal study. The 2-year results, which were the foundation of FDA approval, were presented in November 2017, and were recently published in the journal Ophthalmology.
- Bausch + Lomb Announces New Divisional Leadership in the UShttps://modernod.com/news/bausch-lomb-announces-new-divisional-leadership-in-the-us/2476487/Bausch + Lomb announced the appointment of new leadership in its Pharmaceuticals and Consumer Health Care divisions in the United States. Yolande Barnard, formerly the vice president, marketing and sales, U.S. Neurology, Bausch Health, will now serve as vice president and general manager,
- US Military Develops Mobile Application to Treat Eye Injurieshttps://modernod.com/news/us-military-develops-mobile-application-to-treat-eye-injuries/2476479/The U.S. military medical researchers are developing a mobile application to connect combat medics with on-call ophthalmologists either in-theater or at a clinic to treat eye injuries of soldiers in the field, according to a
- STAAR Surgical Celebrates 1 Million Lens Milestone for Implantable Collamer Lenshttps://modernod.com/news/staar-surgical-celebrates-1-million-lens-milestone-for-implantable-collamer-lens/2476459/STAAR Surgical announced that more than 1 million Visian implantable collamer lenses (ICLs) have been implanted globally. Currently approved versions of the ICL available in more than 75 countries around the world address the explosive growth of myopia, the need for distance vision cor
- Alcon Debuts as Independent, Publicly Traded Companyhttps://modernod.com/news/alcon-debuts-as-independent-publicly-traded-company/2476453/After 8 years under Novartis ownership, Alcon is officially an independent, publicly traded company. On Tuesday, Alcon completed its separation from Novartis and its shares begin trading on the SIX Swiss Exchange and New York Stock Exchange under the symbol “ALC.” American depositary recei
- Ocular Therapeutix Announces Supplemental NDA Accepted by FDA for Dextenzahttps://modernod.com/news/ocular-therapeutix-announces-supplemental-nda-accepted-by-fda-for-dextenza/2476429/Ocular Therapeutix announced the FDA has accepted the filing of the supplemental new drug application (sNDA) for Dextenza (dexamethasone ophthalmic insert) to include the treatment of ocular inflammation following ophthalmic surgery in its label. The notice of acceptance confirms the FDA has comp
- Alcon Launches Expanded Parameters for Dailies AquaComfort Plus Toric Contact Lenseshttps://modernod.com/news/alcon-launches-expanded-parameters-for-dailies-aquacomfort-plus-toric-contact-lenses/2476425/Alcon has introduced a broader range of parameters for its Dailies AquaComfort Plus Toric contact lenses, giving it the most parameters of any daily disposable contact lens for people with astigmatism, according to a company news release. With this expansion, eye care professionals (ECPs) will ha
- Tangible Science Launches Tangible Clean Multi-Purpose Solution for Tangible Hydra-PEG Coated Lenseshttps://modernod.com/news/tangible-science-launches-tangible-clean-multi-purpose-solution-for-tangible-hydra-peg-coated-lenses/2476412/Tangible Science launched a multi-purpose cleaning solution for Tangible Hydra-PEG coated lenses – Tangible Clean. The solution simplifies care for coated gas permeable (GP) lenses and can be used for cleaning, conditioning, disinfecting, protein removal, rinsing and storing them safely. Tangible
- Allergan Agrees to Split CEO, Chairman Roles at Next Leadership Transitionhttps://modernod.com/news/allergan-agrees-to-split-ceo-chairman-roles-at-next-leadership-transition/2476413/Allergan disclosed in a US Securities and Exchange Commission filing on Friday that it has agreed to split its chairman and chief executive roles, both currently held by CEO Brent Saunders, at the next leadership transition. The company said that splitting the roles now, as hedge fund Appaloosa h
- Study: Excess Hormones Could Cause a Condition That Can Lead to Blindness in Womenhttps://modernod.com/news/study-excess-hormones-could-cause-a-condition-that-can-lead-to-blindness-in-women/2476403/Research led by the University of Birmingham, UK, has found that increased levels of hormones including testosterone could cause a brain condition that can lead to blindness in women. Idiopathic Intracranial Hypertension—also known as IIH—is caused by high pressure in the brain with conseq